XML 49 R31.htm IDEA: XBRL DOCUMENT
v3.21.2

Derivative Financial Instruments (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Volume and fair value positions of derivative instruments and location in the Consolidated Statement of Financial Position |
Summary of the volume and fair value positions of derivative instruments as of June 30, 2021
($ in millions, except number of contracts) |  |  | Volume (1) |  |  |  |  |  |
Balance sheet location |  | Notional amount |  | Number of contracts |  | Fair value, net |  | Gross asset |  | Gross liability
Asset derivatives |  |  |  |  |  |  |  |  |  |  |
Derivatives not designated as accounting hedging instruments |  |  |  |  |  |  |  |  |  |
Interest rate contracts |  |  |  |  |  |  |  |  |  |  |
Futures | Other assets |  | n/a |  | 280 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Equity and index contracts |  |  |  |  |  |  |  |  |  |  |
Options | Other investments |  | n/a |  | 15,061 |  |  | 25 |  |  | 25 |  |  | — |
Futures | Other assets |  | n/a |  | 1,183 |  |  | — |  |  | — |  |  | — |
Total return index contracts |  |  |  |  |  |  |  |  |  |  |
Total return swap agreements – fixed income | Other investments |  | $ | 50 |  |  | n/a |  | 1 |  |  | 1 |  |  | — |
Foreign currency contracts |  |  |  |  |  |  |  |  |  |  |
Foreign currency forwards | Other investments |  | 593 |  |  | n/a |  | 6 |  |  | 16 |  |  | (10) |
Embedded derivative financial instruments |  |  |  |  |  |  |  |  |  |
Other embedded derivative financial instruments | Other investments |  | 750 |  |  | n/a |  | — |  |  | — |  |  | — |
Credit default contracts |  |  |  |  |  |  |  |  |  |  |
Credit default swaps – buying protection | Other investments |  | 61 |  |  | n/a |  | (3) |  |  | — |  |  | (3) |
Credit default swaps – selling protection | Other investments |  | 905 |  |  | n/a |  | 19 |  |  | 19 |  |  | — |
Assets held for sale |  |  | 221 |  |  | 2,601 |  |  | 180 |  |  | 182 |  |  | (2) |
Total asset derivatives |  |  | $ | 2,580 |  |  | 19,125 |  |  | $ | 228 |  |  | $ | 243 |  |  | $ | (15) |
Liability derivatives |  |  |  |  |  |  |  |  |  |  |
Derivatives not designated as accounting hedging instruments |  |  |  |  |  |  |  |  |  |
Interest rate contracts |  |  |  |  |  |  |  |  |  |  |
Futures | Other liabilities & accrued expenses |  | n/a |  | 1,073 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Equity and index contracts |  |  |  |  |  |  |  |  |  |  |
Options | Other liabilities & accrued expenses |  | n/a |  | 15,000 |  |  | (13) |  |  | — |  |  | (13) |
Futures | Other liabilities & accrued expenses |  | n/a |  | 693 |  |  | — |  |  | — |  |  | — |
Foreign currency contracts |  |  |  |  |  |  |  |  |  |  |
Foreign currency forwards | Other liabilities & accrued expenses |  | $ | 10 |  |  | n/a |  | — |  |  | — |  |  | — |
Credit default contracts |  |  |  |  |  |  |  |  |  |  |
Credit default swaps – buying protection | Other liabilities & accrued expenses |  | 102 |  |  | n/a |  | (10) |  |  | — |  |  | (10) |
Liabilities held for sale |  |  | 2,179 |  |  | 2,525 |  |  | (601) |  |  | 2 |  |  | (603) |
Total liability derivatives |  |  | 2,291 |  |  | 19,291 |  |  | (624) |  |  | $ | 2 |  |  | $ | (626) |
Total derivatives |  |  | $ | 4,871 |  |  | 38,416 |  |  | $ | (396) |  |  |  |  |
(1) Volume for OTC and cleared derivative contracts is represented by their notional amounts. Volume for exchange traded derivatives is represented by the number of contracts, which is the basis on which they are traded. (n/a = not applicable)
Summary of the volume and fair value positions of derivative instruments as of December 31, 2020
($ in millions, except number of contracts) |  |  | Volume |  |  |  |  |  |
Balance sheet location |  | Notional amount |  | Number of contracts |  | Fair value, net |  | Gross asset |  | Gross liability
Asset derivatives |  |  |  |  |  |  |  |  |  |  |
Derivatives not designated as accounting hedging instruments |  |  |  |  |  |  |  |  |  |
Interest rate contracts |  |  |  |  |  |  |  |  |  |  |
Futures | Other assets |  | n/a |  | 290 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Equity and index contracts |  |  |  |  |  |  |  |  |  |  |
Options | Other investments |  | n/a |  | 56 |  |  | 6 |  |  | 6 |  |  | — |
Futures | Other assets |  | n/a |  | 905 |  |  | 1 |  |  | 1 |  |  | — |
Foreign currency contracts |  |  |  |  |  |  |  |  |  |  |
Foreign currency forwards | Other investments |  | $ | 291 |  |  | n/a |  | 4 |  |  | 9 |  |  | (5) |
Embedded derivative financial instruments |  |  |  |  |  |  |  |  |  |  |
Other embedded derivative financial instruments | Other investments |  | 750 |  |  | n/a |  | — |  |  | — |  |  | — |
Credit default contracts |  |  |  |  |  |  |  |  |  |  |
Credit default swaps – buying protection | Other investments |  | 60 |  |  | n/a |  | (3) |  |  | — |  |  | (3) |
Credit default swaps – selling protection | Other investments |  | 750 |  |  | n/a |  | 13 |  |  | 13 |  |  | — |
Assets held for sale |  |  | 158 |  |  | 3,189 |  |  | 185 |  |  | 189 |  |  | (4) |
Total asset derivatives |  |  | $ | 2,009 |  |  | 4,440 |  |  | $ | 206 |  |  | $ | 218 |  |  | $ | (12) |
Liability derivatives |  |  |  |  |  |  |  |  |  |  |
Derivatives not designated as accounting hedging instruments |  |  |  |  |  |  |  |  |  |
Interest rate contracts |  |  |  |  |  |  |  |  |  |  |
Futures | Other liabilities & accrued expenses |  | n/a |  | 705 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Equity and index contracts |  |  |  |  |  |  |  |  |  |  |
Futures | Other liabilities & accrued expenses |  | n/a |  | 666 |  |  | — |  |  | — |  |  | — |
Total return index contracts |  |  |  |  |  |  |  |  |  |  |
Total return swap agreements – fixed income | Other liabilities & accrued expenses |  | $ | 50 |  |  | n/a |  | — |  |  | — |  |  | — |
Foreign currency contracts |  |  |  |  |  |  |  |  |  |  |
Foreign currency forwards | Other liabilities & accrued expenses |  | 250 |  |  | n/a |  | (9) |  |  | 1 |  |  | (10) |
Credit default contracts |  |  |  |  |  |  |  |  |  |  |
Credit default swaps – buying protection | Other liabilities & accrued expenses |  | 638 |  |  | n/a |  | (16) |  |  | — |  |  | (16) |
Credit default swaps – selling protection | Other liabilities & accrued expenses |  | 4 |  |  | n/a |  | — |  |  | — |  |  | — |
Liabilities held for sale |  |  | 2,240 |  |  | 2,737 |  |  | (630) |  |  | 1 |  |  | (631) |
Total liability derivatives |  |  | 3,182 |  |  | 4,108 |  |  | (655) |  |  | $ | 2 |  |  | $ | (657) |
Total derivatives |  |  | $ | 5,191 |  |  | 8,548 |  |  | $ | (449) |  |  |  |  |
Schedule of gross and net amount for the Company's OTC derivatives subject to enforceable master netting arrangements |
Gross and net amounts for OTC derivatives (1)
($ in millions) |  |  |  | Offsets |  |  |  |  |  |
| Gross amount |  | Counter-party netting |  | Cash collateral (received) pledged |  | Net amount on balance sheet |  | Securities collateral (received) pledged |  | Net amount
June 30, 2021 |  |  |  |  |  |  |  |  |  |  |  |
Asset derivatives |  | $ | 17 |  |  | $ | (13) |  |  | $ | (1) |  |  | $ | 3 |  |  | $ | — |  |  | $ | 3 |
Liability derivatives |  | (13) |  |  | 13 |  |  | — |  |  | — |  |  | — |  |  | — |
December 31, 2020 |  |  |  |  |  |  |  |  |  |  |  |
Asset derivatives |  | $ | 10 |  |  | $ | (9) |  |  | $ | — |  |  | $ | 1 |  |  | $ | — |  |  | $ | 1 |
Liability derivatives |  | (19) |  |  | 9 |  |  | 9 |  |  | (1) |  |  | — |  |  | (1) |
(1)All OTC derivatives are subject to enforceable master netting agreements.
Gains and losses from valuation, settlements, and hedge ineffectiveness, fair value hedges and derivatives not designated as hedges |
Gains (losses) from valuation and settlements reported on derivatives not designated as accounting hedges
($ in millions) |  | Realized capital gains (losses) |  |  |  | Operating costs and expenses |  | Total gain (loss) recognized in net income on derivatives
Three months ended June 30, 2021 |  |  |  |  |  |  |  |
Interest rate contracts |  | $ | 2 |  |  |  |  | $ | — |  |  | $ | 2 |
Equity and index contracts |  | (6) |  |  |  |  | 14 |  |  | 8 |
Foreign currency contracts |  | (2) |  |  |  |  | — |  |  | (2) |
Credit default contracts |  | 1 |  |  |  |  | — |  |  | 1 |
Total return swaps - fixed income |  | 2 |  |  |  |  | — |  |  | 2 |
Total |  | $ | (3) |  |  |  |  | $ | 14 |  |  | $ | 11 |
Six months ended June 30, 2021 |  |  |  |  |  |  |  |
Interest rate contracts |  | $ | 1 |  |  |  |  | $ | — |  |  | $ | 1 |
Equity and index contracts |  | (8) |  |  |  |  | 30 |  |  | 22 |
Foreign currency contracts |  | 8 |  |  |  |  | — |  |  | 8 |
Credit default contracts |  | 5 |  |  |  |  | — |  |  | 5 |
Total return swaps - fixed income |  | 2 |  |  |  |  | — |  |  | 2 |
Total |  | $ | 8 |  |  |  |  | $ | 30 |  |  | $ | 38 |
Three months ended June 30, 2020 |  |  |  |  |  |  |  |
Interest rate contracts |  | $ | 1 |  |  |  |  | $ | — |  |  | $ | 1 |
Equity and index contracts |  | (3) |  |  |  |  | 31 |  |  | 28 |
Foreign currency contracts |  | (4) |  |  |  |  | — |  |  | (4) |
Credit default contracts |  | 13 |  |  |  |  | — |  |  | 13 |
Total return swaps - fixed income |  | 7 |  |  |  |  | — |  |  | 7 |
Total return swaps - equity index |  | — |  |  |  |  | — |  |  | — |
Total |  | $ | 14 |  |  |  |  | $ | 31 |  |  | $ | 45 |
Six months ended June 30, 2020 |  |  |  |  |  |  |  |
Interest rate contracts |  | $ | 36 |  |  |  |  | $ | — |  |  | $ | 36 |
Equity and index contracts |  | 30 |  |  |  |  | (14) |  |  | 16 |
Foreign currency contracts |  | 21 |  |  |  |  | — |  |  | 21 |
Credit default contracts |  | 3 |  |  |  |  | — |  |  | 3 |
Total return swaps - fixed income |  | (2) |  |  |  |  | — |  |  | (2) |
Total return swaps - equity index |  | 4 |  |  |  |  | — |  |  | 4 |
Total |  | $ | 92 |  |  |  |  | $ | (14) |  |  | $ | 78 |
Counterparty credit exposure by counterparty credit rating |
OTC derivatives counterparty credit exposure by counterparty credit rating
($ in millions) |  | June 30, 2021 |  | December 31, 2020
Rating (1) |  | Number of counter- parties |  | Notional amount (2) |  | Credit exposure (2) |  | Exposure, net of collateral (2) |  | Number of counter- parties |  | Notional amount (2) |  | Credit exposure (2) |  | Exposure, net of collateral (2)
A+ |  | 2 |  |  | $ | 190 |  |  | $ | 6 |  |  | $ | 1 |  |  | 1 |  |  | $ | 186 |  |  | $ | 4 |  |  | $ | — |
A |  | 1 |  |  | 236 |  |  | 3 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Total |  | 3 |  |  | $ | 426 |  |  | $ | 9 |  |  | $ | 1 |  |  | 1 |  |  | $ | 186 |  |  | $ | 4 |  |  | $ | — |
(1) Allstate uses the lower of S&P’s or Moody’s long-term debt issuer ratings. (2) Only OTC derivatives with a net positive fair value are included for each counterparty.
Derivative instruments with credit features in a liability position, including fair value of assets and collateral netted against the liability |
($ in millions) |  | June 30, 2021 |  | December 31, 2020
Gross liability fair value of contracts containing credit-risk-contingent features |  | $ | 12 |  |  | $ | 19 |
Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs |  | (9) |  |  | (6) |
Collateral posted under MNAs for contracts containing credit-risk-contingent features |  | (3) |  |  | (13) |
Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently |  | $ | — |  |  | $ | — |
Schedule of derivative CDS notional amount by credit rating and fair value of protection sold |
CDS notional amounts by credit rating and fair value of protection sold
($ in millions) |  | Notional amount |  |
| AAA |  | AA |  | A |  | BBB |  | BB and lower |  | Total |  | Fair value
June 30, 2021 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Single name |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 5 |  |  | $ | 5 |  |  | $ | — |
Index |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt |  | 7 |  |  | 14 |  |  | 179 |  |  | 610 |  |  | 90 |  |  | 900 |  |  | 19 |
Total |  | $ | 7 |  |  | $ | 14 |  |  | $ | 179 |  |  | $ | 610 |  |  | $ | 95 |  |  | $ | 905 |  |  | $ | 19 |
December 31, 2020 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Single name |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 4 |  |  | $ | 4 |  |  | $ | — |
Index |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt |  | 6 |  |  | 12 |  |  | 156 |  |  | 492 |  |  | 84 |  |  | 750 |  |  | 13 |
Total |  | $ | 6 |  |  | $ | 12 |  |  | $ | 156 |  |  | $ | 492 |  |  | $ | 88 |  |  | $ | 754 |  |  | $ | 13 |

X
- Definition Tabular disclosure of derivative and other financial assets and liabilities that are subject to offsetting, including master netting arrangements. + References No definition available. + Details
Name: | all_OffsettingAssetsAndLiabilitiesTableTextBlock
Namespace Prefix: | all_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of CDS notional amounts by credit rating and fair value of protection sold. + References No definition available. + Details
Name: | all_ScheduleOfDerivativeCDSNotionalAmountByCreditRatingAndFairValueOfProtectionSoldTableTextBlock
Namespace Prefix: | all_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of counterparty credit exposure by counterparty credit rating. + References No definition available. + Details
Name: | all_ScheduleOfDerivativeCounterpartyCreditExposureTableTextBlock
Namespace Prefix: | all_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of fair value of derivative instruments with termination, cross-default or collateral credit-risk-contingent features that are in a liability position and the fair value of assets and collateral that are netted against the liability. + References No definition available. + Details
Name: | all_ScheduleOfDerivativeInstrumentsCreditFeaturesInLiabilityPositionAndNettingTableTextBlock
Namespace Prefix: | all_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of gains and losses from valuation, settlements, and hedge ineffectiveness reported on derivatives used in fair value hedging relationships and derivatives not designated as accounting hedging instruments in the statement of operations. + References No definition available. + Details
Name: | all_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceValuationSettlementsHedgeIneffectivenessFairValueHedgesAndNotDesignatedHedgesTableTextBlock
Namespace Prefix: | all_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration